Niperian Pharmaceuticals is a pharmaceutical company shaped by scholars and researchers associated with the National Institute of Pharmaceutical Education and Research (NIPER). It describes its approach as grounded in multidisciplinary expertise, including pharmaceutical analysis, medicinal chemistry, pharmacology and toxicology, pharmaceutics, regulatory affairs, and natural-products research. The company says its work is supported by more than 10 research scholars and over 20 Niperian students, and highlights five years of experience.

Niperian Pharma’s featured products and services focus on fertility and reproductive health. Its website presents an advanced fertility formula for advanced maternal age and promotes products addressing ovarian cysts, hormonal imbalance, irregular menstrual cycles, excess androgens, and idiopathic female infertility. It also refers to support for infertility associated with advanced paternal age. These offerings are framed as responses to underlying fertility concerns.

The company’s stated vision is to advance ethical, science-driven pharmaceutical innovation and make therapies more accessible. It also highlights ongoing assistance from its scholars and students.